Direct detection of polioviruses using a recombinant poliovirus receptor.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2021
2021
Historique:
received:
11
03
2021
accepted:
12
10
2021
entrez:
2
11
2021
pubmed:
3
11
2021
medline:
24
12
2021
Statut:
epublish
Résumé
Polioviruses are positive-sense, single-stranded RNA picornaviruses and the principal cause of poliomyelitis. Global poliovirus surveillance has relied on poliovirus isolation in cells, which may take a minimum of 10 days, involves maintaining two cell lines, and propagates virus in high titers. With eradication underway, a major objective of the Global Polio Eradication Initiative (GPEI) is to develop culture-independent detection of polioviruses as an alternative method to complement the current virus isolation technique. A culture-independent method on poliovirus-positive stool suspensions was assessed with commercially available recombinant soluble poliovirus receptor (PVR) coupled to Histidine (His) tags. Viral RNA was screened by quantitative real-time reverse transcription PCR using the poliovirus intratypic differentiation kit. Poliovirus recovery was optimized with PVR-His-tagged protein and buffers supplemented with polyethylene glycol. To validate the poliovirus-PVR-His tag purification assay, 182 poliovirus-positive stools of programmatic importance were parallel tested against the GPLN-accepted virus isolation method. The PVR-His tag enrichment method detected poliovirus in 164 of 171 poliovirus-positive stools, whereas the virus isolation method misidentified 38 stools as poliovirus-negative (McNemar χ2 p<0.0001). Using this method in combination with RNA extraction, viral RNA recovery increased and showed similar (WPV1) or higher (Sabin 1) sensitivity than the World Health Organization accredited variation of the virus isolation method. The PVR-His enrichment method could be a viable addition to poliovirus surveillance; similar methods have the potential to capture other human pathogens such as EV71 using an appropriate soluble His tag receptor.
Identifiants
pubmed: 34727100
doi: 10.1371/journal.pone.0259099
pii: PONE-D-21-08126
pmc: PMC8562806
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0259099Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Trends Microbiol. 2002 Jul;10(7):324-31
pubmed: 12110211
Cancer. 1969 Sep;24(3):520-6
pubmed: 4241949
Virology. 1981 Jan 30;108(2):405-23
pubmed: 6258294
MMWR Morb Mortal Wkly Rep. 2017 Apr 07;66(13):359-365
pubmed: 28384129
Sci Rep. 2020 May 14;10(1):7939
pubmed: 32409751
J Med Virol. 1999 Jun;58(2):188-92
pubmed: 10335869
J Clin Microbiol. 2020 Aug 24;58(9):
pubmed: 32611795
J Gen Virol. 1997 Jan;78 ( Pt 1):1-11
pubmed: 9010279
Lancet Infect Dis. 2015 Nov;15(11):1273-82
pubmed: 26318714
Cell. 2015 Feb 12;160(4):619-630
pubmed: 25679758
Cell. 1989 Mar 10;56(5):855-65
pubmed: 2538245
J Clin Microbiol. 2018 Jan 24;56(2):
pubmed: 29212703
Nat Med. 2009 Jul;15(7):798-801
pubmed: 19543282
J Clin Microbiol. 2015 Jan;53(1):73-8
pubmed: 25339406
J Clin Microbiol. 2013 Aug;51(8):2717-20
pubmed: 23698530
Appl Environ Microbiol. 2011 Aug;77(15):5141-8
pubmed: 21622793
Virology. 2015 Aug;482:28-31
pubmed: 25817402
J Clin Microbiol. 2010 Aug;48(8):2698-702
pubmed: 20519462